Related Experiment Video
Updated: Aug 7, 2026
Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
[Reevaluation of the typing criteria for patients with chronic severe hepatitis]
Zhen Zeng1, Yu-kun Han, Hua Geng
1The No. 302 Hospital of the People's Liberation Army, Beijing 100039, China.
Insights
This study differentiates chronic severe liver disease into two types: chronic hepatitis-associated (Type I) and cirrhosis-associated (Type II), based on distinct clinical features and prognoses. Decompensated cirrhosis typing remains unchanged.
Area of Science:
- Hepatology
- Internal Medicine
- Clinical Research
Context:
- Chronic severe liver disease presents complex clinical challenges.
- Distinguishing between chronic hepatitis and cirrhosis is crucial for patient management.
- Decompensated liver function necessitates precise diagnostic criteria.
Purpose:
- To investigate clinical features and refine typing criteria for chronic severe hepatitis and decompensated liver function.
- To compare clinical characteristics and outcomes across different stages of liver disease.
- To establish more accurate classifications for severe liver conditions.
Summary:
- Retrospective analysis of 106 decompensated cirrhosis, 124 chronic liver failure (CLF) I, and 100 CLF II cases revealed significant differences in age, biochemical markers (albumin, globulin, ALT, AST, cholinesterase), and clinical manifestations (ascites, hepatic encephalopathy).
- Prognosis was notably better in the decompensated cirrhosis group compared to CLF I and CLF II.
- The study suggests classifying chronic severe liver disease into Type I (chronic hepatitis-associated) and Type II (cirrhosis-associated), with unchanged criteria for decompensated cirrhosis.
Impact:
- Provides a refined classification system for chronic severe liver disease, aiding in more accurate diagnosis and treatment planning.
- Highlights the importance of differentiating disease subtypes for predicting patient outcomes.
- Contributes to a better understanding of the clinical spectrum of advanced liver disease.
Background:
To study the clinical features and more reasonable typing criteria for patients with chronic severe hepatitis and decompensated liver function.
Methods:
Data of 106 cases of decompensated cirrhosis, 124 cases of chronic liver failure and 100 cases of chronic liver failure (chronic liver failure group I, CLF I) with decompensated cirrhosis (chronic liver failure group II, CLF II) were analyzed retrospectively.
Results:
(1) The ages were youngest in chronic liver failure group I (about 30 years), and the oldest in decompensated cirrhosis group (about 50 years). (2) There were significant differences in albumin, globulin, ALT, AST, protruding activity, blood glucose, blood lipid and cholinesterase among the three groups. (3) There was no significant difference in upper digestive tract bleeding and hepatorenal syndrome, on the other hand, there was significant difference in ascites and hepatic encephalopathy. (4) The prognosis of the patients in decompensated cirrhosis group was better than that of chronic liver failure group I and chronic liver failure group II.
Conclusion:
The clinical feature and prognosis in three groups were different, so, it is suggested that chronic severe liver disease be divided into 2 types: one is chronic severe liver disease type I, which is associated with chronic hepatitis, and the other is chronic severe liver disease type II, which is associated with cirrhosis, and the typing criteria for decompensated cirrhosis remains unchanged.
Related Concept Videos
01:25Hepatitis
01:28Viral Hepatitis I: Introduction
01:23Cirrhosis I: Introduction